• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4606053)   Today's Articles (3541)   Subscriber (49373)
For: Zhang S, Li L, Yu P, Wu C, Wang X, Liu M, Deng S, Guo C, Tan R. A deep learning model for drug screening and evaluation in bladder cancer organoids. Front Oncol 2023;13:1064548. [PMID: 37168370 PMCID: PMC10164950 DOI: 10.3389/fonc.2023.1064548] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2022] [Accepted: 02/06/2023] [Indexed: 05/13/2023]  Open
Number Cited by Other Article(s)
1
Ertl I, Shariat SF, Berger W, Englinger B. Preclinical models for bladder cancer therapy research. Curr Opin Urol 2024;34:244-250. [PMID: 38630912 PMCID: PMC11155278 DOI: 10.1097/mou.0000000000001182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/19/2024]
2
Michaud É, Mansure JJ, Kassouf W. Integrating novel immunotherapeutic approaches in organ-preserving therapies for bladder cancer. Br J Pharmacol 2023. [PMID: 38092703 DOI: 10.1111/bph.16300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2023] [Revised: 11/22/2023] [Accepted: 11/26/2023] [Indexed: 01/17/2024]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA